Vascular endothelial growth factor (VEGF), through activation of its endoth
elial receptors VEGFR-1 and VEGFR-2, is an important positive modulator of
tumor angiogenesis and edema in solid tumors such as malignant astrocytomas
. Neuropilin-1 (Npn-l) is a transmembrane receptor expressed by both endoth
elial and non-endothelial cells, including tumor cells. Npn-l has been post
ulated to function as a co-factor in activation of the biologically relevan
t VEGFR-2, by the most abundant VEGF165 isoform. However, the function of N
pn-1 in normal and pathological angiogenesis, its expression pattern in rel
ation to VEGF in tumors such as astrocytomas and whether it is similarly or
differentially regulated compared to VEGF remain unknown. In our study, th
e expression pattern of Npn-l and VEGF by human astrocytoma cell lines and
specimens was closely correlated and associated with malignant astrocytomas
, Mitogens, such as epidermal growth factor and activation of p21-Ras, prev
iously demonstrated to be relevant in astrocytoma proliferation and inducti
on of VEGF, also induce Npn-l expression. Hypoxia, the main physiological i
nducer of VEGF expression, decreased Npn-l expression. Increased Npn-l expr
ession was also demonstrated in a transgenic mouse astrocytoma model. Astro
cytomas are an ideal system for furthering our understanding of the functio
nal relevance, if any, of Npn-l in tumor angiogenesis, (C) 2000 Wiley-Liss,
Inc.